Gender
Male
- About
- Blog Posts
- Friends
- Discussions
- Events
- Groups
- Photos
- Videos
- Comment Wall
Location
Houston (NASA/JSC Area)
Birthday:
March 21
Age:
81
You need to be a member of The International NanoScience Community - Nanopaprika.eu to add comments!
Join The International NanoScience Community - Nanopaprika.eu
Comments are closed.
Comments
I request the people going through my profile to drop some suggestions to let me acknowledge about my future plans(MS). I am deeply interested in Nanobiotechnology, specially forensic science,medicines or sumthng related to human anatomy concepts. I would be happy if I would get some interesting suggestions and advices too.Please do tell me that is it feasible, taking my background into consideration to have such kind of interest that is quite different from eachother i request you to suggest some wayz so that i can corelate my interest wth my current stream.
THANK YOU
Thanks MM. i'll record the particulars. It reminds me of a recent report of the flat 'onion roll' NPs created by a team. One member of that team remarked they do not create NPs randomly. Instead they determine a need for a specific application and then fabricate the suitable nanovectors. I've had some productive communication with one of the researchers investigating nanotoxicity. She and collaborators' at NCSU are not as gloomy and tedious as Lewinski, N. et al. article in Small. In defense of the latter article it is in no way short on data. Very thorough indeed. Yet I agree with Chris Tourney of the U. of South Carolina NanoCenter's assessment of the Small article. After making my way through it the 'fear and loathing' of dread was almost overwhelming. Then near the end they write that "based on the present studies published...[it would be premature to conclude] that nanoparticles are inherently dangerous." Quite a rollarcoaster ride. As you are well aware biocompatibilty and hermetic encapsulation are some of the crucial ways to approach the challeges. The NCSU researcher kindly shared some of their specific methods, results, info and conclusions. Two German researchers in NanoToday say size, shape, material, production process and even some by-product impurities could contribute to cytotoxicity. I was fascinated by how Boston Childrens Hospital team made a new nanoformulation for a cancer drug that showed much promise by inducing remission, etc. Side-effect was the old drug-delivery caused memory and cognition problems. The BCH team increased it size using polymers to prevent its penetration of the blood-brain barrier. Beauty in simplicity.
I do always appreciate the newest ideas, insights, innovations and inventions in nanomed and all aspects of nanoscitech.
david
I noticed we share similar interests. Always good to find a kindred explorer. I'll read the info you have here.
Have you heard or read about the new motor-type that a Japanese firm has secured an international patent for?
I do not really intend to sound so cryptic but I'm going over what information is available to me. Its really rather exciting material.
best always,
david
I am very proud to be able to show this to you as I was involved with this for many years. As most of you know, Rick Smalley and I were involved with several things which have come into manifestation. This is just another example.
News > Nanowerk Research and General News >
Posted: April 22, 2008
Animation reveals nanotechnology role in breakthrough cancer treatment
(Nanowerk News) Hybrid Medical Animation is offering audiences a second chance to catch a 60 Minutes segment that features their original animation on nanoparticles.
The segment, about a promising new cancer treatment, will be available for viewing on the Minneapolis studio s Web site.
Originally airing April 13, the 60 Minutes piece, entitled "The Kanzius Machine: A Cancer Cure?", focuses on an experimental nanotechnology cancer-treating machine invented by a former business man with no medical or cancer research training. John Kanzius, diagnosed with leukemia himself, developed a prototype that uses radio waves and activated nanoparticles to kill cancer cells.
The Hybrid animation, produced exclusively for 60 Minutes, demonstrates how gold nanoparticles, circulated throughout the body, can specifically target cancerous tissue. Once the particles attach to the cancer cells, the Kanzius machine emits radio waves that excite the nanoparticles and causes them to heat up. The treatment has been shown by Kanzius and others to destroy cancerous cells while sparing healthy surrounding tissue, with virtually no side effects.
During the segment, Dr. Steven Curley, a liver cancer surgeon with M.D. Anderson, presents the animation to 60 Minutes reporter, Leslie Stahl. Gosh, it does look like one of those science fiction movies, Stahl remarks as the animation concludes.
Hybrid Medical Animation, Inc. (http://www.hybridmedicalanimation.com/), produces medical and scientific 3D animation for the pharmaceutical, medical device, and biotechnology industries. The Minneapolis-based studio employs ten in-house animators and a board-certified physician as producer and medical director. Hybrid has won numerous awards for animation excellence.
Source: Hybrid Medical Animation
very glad to be involved!
As you might well imagine I am having a Ball!
Thank you for the "friend invitation" ... much appreciated. I have taken a quick look at the nanocomputer.org website, and am highly intrigued by what you and your group are doing ... specifically the educational aspects of your efforts. I expect to be in the Houston area on or around March 17th ... so perhaps there is a possibility of being able to meet in person. If not, then perhaps another time. Feel free to e-mail me at asweeney@ucf.edu .
Best wishes,
Aldrin
Aldrin E. Sweeney, Ph.D.
Editor-in-Chief
JOURNAL OF NANO EDUCATION
http://www.aspbs.com/jne
http://www.aspbs.com/nsee
Dear Michal! I visit your webpage, and it is very interesting. If you have interest for partnership of your site and NanoSciance Network, please contact me on andras.paszternak@nanopaprika.eu e-mail adress.
Andras Paszternak, editor